Biotage

Biotage FCF/Debt

Delisted

The Free Cash Flow to Debt Ratio of Biotage (BIOT.ST) as of Oct 28, 2026 is 97.60 %. In the previous year, Free Cash Flow to Debt Ratio was 99.61 % — a change of -2.02% (lower).

FCF/Debt

97.60 %

YoY

-2.02%

Last updated:

Free Cash Flow to Debt Ratio of Biotage is 2024 97.60 % . Free Cash Flow to Debt Ratio of Biotage was 2023 99.61 % . It decreases by -2.02% lower compared to the previous year.

The Biotage FCF/Debt history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF/Debt
Date
FCF/Debt
Jan 1, 2014
967.04 SEK
Jan 1, 2018
98.58 SEK
Jan 1, 2019
98.50 SEK
Jan 1, 2020
134.72 SEK
Jan 1, 2021
146.31 SEK
Jan 1, 2022
124.88 SEK
Jan 1, 2023
99.61 SEK
Jan 1, 2024
97.60 SEK
The Biotage FCF/Debt history
YEARFCF/DebtYoY
97.60 %-2.02%
99.61 %-20.24%
124.88 %-14.64%
146.31 %+8.60%
134.72 %+36.77%
98.50 %-0.08%
98.58 %-89.81%
967.04 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Biotage Stock analysis

What does Biotage do? Biotage AB is a Swedish company founded in 1983. Since then, the company has become an international leader in the development, manufacturing, and marketing of equipment, chemicals, and accessories for organic and medicinal chemistry, pharmacy, biochemistry, and food analysis. The company's business model is based on the development and marketing of innovative instruments and technologies for analytics and chromatography. Consumables and accessory products are also an important part of the business model. Biotage offers customized solutions tailored to each customer's specific needs. Biotage systems are widely used in the pharmaceutical, biotech, and academic sectors. The company is divided into four main divisions: chromatography, spectroscopy, analytics, and synthesis. In the chromatography division, Biotage offers a wide range of systems for sample preparation and analysis, including flash chromatography systems, HPLC systems, and automation solutions for column development. In the spectroscopy division, Biotage offers systems for molecular structure determination, including NMR spectrometers and FT-IR spectrometers. In the analytics division, the company specializes in mass spectrometry and offers a wide range of instruments and accessories, including HPLC-MS systems, MALDI-TOF systems, and LC-MS applications. In the synthesis division, the focus is on the development and marketing of tools for the synthesis, purification, and analysis of peptides and synthesis kits. Biotage is also known for its wide range of chemicals and accessory products. The company offers a variety of solvents, catalysts, reagents, and separation columns that can be used in organic, pharmaceutical, and biological synthesis. Accessory products include items such as activated carbon filter cartridges or membranes for various chromatography systems. Despite the wide range of products, Biotage has focused on specialized markets, particularly drug research and development, peptide synthesis, and the production of specialty chemicals. In these markets, the devices and chemicals are used to develop and produce medications and important blockbuster compounds. In conclusion, Biotage is a company that focuses on the development and marketing of instruments and technologies for analytics and chromatography. Thanks to its strong market presence and innovative products, the company has become an internationally recognized manufacturer. Biotage is headquartered in Sweden, but its global network of sales and service centers enables global presence and development. Biotage is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Biotage stock

Free Cash Flow to Debt Ratio of Biotage is 97.60 % in 2024.

Free Cash Flow to Debt Ratio of Biotage changed from 99.61 % to 97.60 %, representing a -2.02% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Free Cash Flow to Debt Ratio Biotage since 2006 – with annual values, charts, and detailed analysis.

FCF/Debt measures the percentage of total debt that could be repaid from free cash flow. It is a stricter measure than OCF/Debt as it accounts for capital expenditures.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Free Cash Flow to Debt Ratio's Biotage with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Biotage

All Key Metrics — Biotage